Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia
Neuropsychiatric Disease and Treatment · 2023-10 · Volume 19 · 2309-2318
DOI: 10.2147/ndt.s435138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2023-10. Verfasst von Luyu Zhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Wuhan Mental Health Center, School of Mental Health and Psychological Sciences, Anhui Medical University, Wuhan, People's Republic of China. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Wuhan Mental Health Center, School of Mental Health and Psychological Sciences, Anhui Medical University, Wuhan, People's Republic of China.
- Department of Psychiatry, Wuhan Mental Health Center, Wuhan, People's Republic of China.
- Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China.
Zitieren
APA
Zhan, L., Yin, H., Gao, Y., Li, Y., & Ma, J. (2023). Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia. Neuropsychiatric Disease and Treatment, Volume 19, 2309-2318. https://doi.org/10.2147/ndt.s435138
Vancouver
Zhan L, Yin H, Gao Y, Li Y, Ma J. Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia. Neuropsychiatric Disease and Treatment. 2023;Volume 19:2309-2318. doi:10.2147/ndt.s435138
BibTeX
@article{Zhan2023,
author = {Zhan, Luyu and Yin, Huimin and Gao, Yujun and Li, Yi and Ma, Jun},
title = {Prevalence and Factors Associated with Subclinical Hypothyroidism in Major Depressive Disorder Patients with Dyslipidemia},
journal = {Neuropsychiatric Disease and Treatment},
year = {2023},
volume = {Volume 19},
pages = {2309--2318},
doi = {10.2147/ndt.s435138}
}
EUVIMED